While it is clear that humans suffer from ''classic'' analgesic nephro
pathy, the causative agents and mechanisms are still not known. A revi
ew of the literature revealed that chronic acetaminophen exposure does
not produce renal papillary necrosis in rodents or humans. In contras
t, while chronic aspirin exposure to rodents results in renal papillar
y necrosis with renal morphological and functional changes similar to
that described in humans, epidemiological studies do not implicate asp
irin alone in human analgesic nephropathy. The difference in the effec
ts of aspirin in humans and rats may be due to the inability of epidem
iological studies to detect aspirin-induced analgesic nephropathy or m
ore likely to the fact that species differences exist, with the rat be
ing more sensitive than humans. With respect to combinations of aspiri
n and acetaminophen, with or without caffeine, there are minimal light
ly controlled studies. In addition, there is little evidence of enhanc
ed renal papillary necrosis in rodents treated with aspirin and acetam
inophen combinations. In summary, it remains to be determined what che
mical entities cause ''classic'' analgesic nephropathy in humans and t
he mechanisms of this toxicity such that preventative measures can be
instituted. Elucidation of the mechanisms of analgesic nephropathy has
been hampered due to the lack of animal models that closely mimic the
human disease. Rodents do not appear to be an appropriate model.